Compare QNCX & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QNCX | CHMI |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.2M | 83.3M |
| IPO Year | 2019 | 2013 |
| Metric | QNCX | CHMI |
|---|---|---|
| Price | $3.54 | $2.64 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $8.00 | $2.75 |
| AVG Volume (30 Days) | ★ 1.2M | 221.1K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 15.21% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $40,202,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $31.73 |
| P/E Ratio | ★ N/A | $140.37 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.72 | $2.17 |
| 52 Week High | $4.55 | $3.68 |
| Indicator | QNCX | CHMI |
|---|---|---|
| Relative Strength Index (RSI) | 57.30 | 68.02 |
| Support Level | $3.74 | $2.47 |
| Resistance Level | $4.55 | $2.62 |
| Average True Range (ATR) | 0.40 | 0.06 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 35.18 | 92.96 |
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.